Surprising results from the Datmouth Atlas of Health Care
Commentary by Zackary Berger MD PhD, PGY-3, Health Care Policy Section Editor
What explains the large variation in health care costs across the country? You …
Surprising results from the Datmouth Atlas of Health Care
Commentary by Zackary Berger MD PhD, PGY-3, Health Care Policy Section Editor
What explains the large variation in health care costs across the country? You …
Commentary by Bani Chander MD, PGY-3
Childhood obesity, foodborne illness and the evil pharmaceutical industy…sorry to start your day off with some gloomy topics, but the news is full of it these days. …
Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. These posts focus on evidenced based answers to clinical questions related to patients seen by our …
Commentary by Marilena S. Antonopoulos, PharmD, Pharmacology Editor
On July 8th, the FDA notified the manufacturers of fluoroquinolone antimicrobial drugs that a Boxed Warning in the product labeling and a Medication Guide for …
Commentary by Howard Leaf, M.D. Assistant Professor, Division of Infectious Diseases and Immunology
Pressure continues to build for healthcare facilities to act to decrease hospital-acquired infections, particularly those associated with MRSA. This is …
Commentary by Judith Brenner MD, Associate Program Director, NYU Internal Medicine Residency Program
Happy July 4th! As we celebrate our nation’s 232nd birthday, I sit here wondering what “shortcuts” might have looked like …
Diseases 2.0 – Bringing you the latest updates on disease pathophysiology and treatment
Commentary By David Goldfarb, M.D. Professor of Medicine, NYU Medical Center, Chief Nephrology Section VA New York Harbor
At the recent meeting of …
317 posts, 67,000 unique visitors from 167 different countries and almost 100,000 hits later and we’re still here. It’s time we evolved…
Welcome to Clinical Correlations Version 2.0. What better day than July …